Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00241 ALI HEALTH
RTNominal unchange2.750 0.000 (0.000%)
Others

20/11/2017 09:44

Ali Health (00241) to place shares to parent's subsidiary

[ET Net News Agency, 20 November 2017] Alibaba Health Information Technology (00241)
said it agreed to place about 442 million new shares at HK$4 per share, representing a
discount of about 4.31% to the closing price of HK$4.18, to Ali JK Nutritional Products
Holding Limited.
The subscription shares represent around 4.5% of the enlarged issued share capital of
Alibaba Health. Upon completion, the shareholding of the subscriber will increase to about
16.59% from 12.66%.
The estimated net proceeds of about HK$1,769 million will be used for repayment of
loans, to fund ongoing business operations and expansion, for completion of previous
committed investments, as well as future strategic acquisitions as and when appropriate
opportunities arise.
The subscriber is wholly-owned by Alibaba Group Holding Limited. (HL)

Remark: Real time quote last updated: 26/04/2024 09:19
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.